2023 Approvals

Zurzuvae approved for treatment of postpartum depression on August 04, 2023

Zurzuvae approved for treatment of postpartum depression on August 04, 2023

What is Zurzuvae prescribed for? Zurzuvae is prescribed to treat postpartum depression in adults.  What is the name of the drug and what does it do? Zurzuvae, pronounced ZUR-zoo-vay, (generic name: zuranolone) is a medication approved for treating postpartum depression (PPD) in adults.  It belongs to a class of drugs known as neuroactive steroids, which...

Voquezna approved for Erosive Esophagitis and GERD by FDA on November, 2023

Voquezna approved for Erosive Esophagitis and GERD by FDA on November, 2023

What is Voquezna prescribed for? Voquenza is indicated for the treatment of Helicobacter pylori (H. pylori) infection in adults. What is the name of the drug and what does it do? Voquezna, pronounced voh-kez-nah, (generic name:vonoprazan) recently approved by the FDA, is a medication designed to treat erosive esophagitis and gastroesophageal reflux disease...